Cold Tumors: A Therapeutic Challenge for Immunotherapy

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Immune checkpoint inhibitors (ICPs) have transformed cancer treatment but show limited response rates.
• A key resistance mechanism is the absence of T cell infiltration in tumors, termed "cold tumors."

Purpose of the Study:

• To review the mechanisms causing T cell exclusion in "cold tumors."
• To discuss therapeutic strategies for converting "cold tumors" into "hot" ones.

Main Methods:

• Literature review of mechanisms behind T cell exclusion.
• Analysis of therapeutic approaches to enhance T cell infiltration and anti-tumor immunity.

Main Results:

• Mechanisms include lack of tumor antigens, impaired antigen presentation, absent T cell activation, and poor homing.
• Therapeutic strategies target these specific mechanisms.
• "Supra-physiological" therapies like bispecific antibodies and CAR T cells show potential across various mechanisms, including in MHC class I-negative tumors.

Conclusions:

• Understanding the factors limiting T cell infiltration is critical for developing effective treatments for "cold tumors."
• Targeted and advanced immunotherapies offer promising avenues to overcome resistance and improve patient outcomes.